Chronic Myelomonocytic Leukemia Clinical Trials

27 studies are recruiting for chronic myelomonocytic leukemia in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Houston, Texas 10 Seattle, Washington 7 Boston, Massachusetts 5 Columbus, Ohio 4 Miami, Florida 4 Cleveland, Ohio 3 Duarte, California 3 Rochester, Minnesota 3 The Bronx, New York 3

Studies, page 2

  1. Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

    A Phase 1, first-in-human study of EP31670, a dual BET and CBP/p300 inhibitor in patients with targeted advanced solid tumors and Hematological Malignancies

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Mayo Clinic Arizona, Phoenix, Arizona
    Locations
    6 in total
    Run by
    Epigenetix, Inc.

    See if you can join NCT05488548 on ClinicalTrials.gov

  2. Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition

    This is a prospective phase I dose-escalation study, with the primary objective to access the MTD and find the RP2D of talazoparib, given in combination with standard of care dosing of pacritinib.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania
    Run by
    Fox Chase Cancer Center

    See if you can join NCT06218628 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.